Lab Automation Market Size, Share & Trends Analysis Report By Process (Continuous Flow, Discrete Processing), By Automation Type (Total Automation Systems, Modular Automation Systems), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Research Methodology

A three-pronged approach was followed for deducing the lab automation market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for lab automation market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of lab automation market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Lab Automation Market Categorization:

The lab automation market was categorized into four segments, namely process (Continuous Flow, Discrete Processing, ), automation type (Total Automation Systems, Modular Automation Systems), end-use (Photometry & Fluorometry, Immunoassay Analysis, Electrolyte Analysis, Other end-uses, Clinical Chemistry Analysis), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The lab automation market was segmented into process, automation type, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The lab automation market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Lab automation market companies & financials:

The lab automation market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• QIAGEN - Qiagen is a company specializing in life sciences and biotechnology, providing Sample to Insight solutions that yield molecular insights. The firm's offerings aid in deriving meaningful insights from intricate biological materials, catering to hospitals and laboratories worldwide. It primarily serves four customer segments—molecular diagnostics, applied testing, pharmaceutical & biotechnology firms, and academic institutions. Qiagen categorizes its products into two types—consumables and instruments. The company's products are sold in over 130 countries globally.

• PERKINELMER, INC. - PerkinElmer, Inc., a U.S.-based firm, is committed to delivering products, solutions, and services to the life sciences, diagnostics, and applied services sectors. The company primarily functions in two divisions: diagnostics and discovery & analytical solutions. The discovery & analytical solutions division provides products like reagents, detection, and imaging technologies & informatics that aid scientists in advancing research in life sciences research and laboratory services markets. Additionally, the company offers analytical solutions, technologies & services for the food, environmental, and industrial sectors. The diagnostics division of the company provides instruments, software products, and reagents that are utilized for the early detection of genetic disorders and infectious disease testing. Products from this division can also be employed for screening & testing genetic abnormalities, diseases, and disorders, including hypothyroidism, Down syndrome, infertility, and various other metabolic diseases. The company caters to biotechnological and pharmaceutical firms, clinical research institutions, private health organizations, medical professionals, government agencies and public health authorities.

• THERMO FISHER SCIENTIFIC, INC. - Thermo Fisher Scientific, Inc. is a renowned manufacturer and distributor of analytical tools, devices, consumables, reagents, software, and services for a variety of uses, including diagnostics, research, manufacturing, and drug discovery. The firm’s operations are divided into four key segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The Life Sciences Solutions segment provides reagents, consumables, and devices that are used in drug discovery and biological & medical research. The Analytical Instruments segment offers consumables, devices, software, and services that are used in a variety of applications in the lab, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic reagents, test kits, devices, culture media, and related products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety labs. The Laboratory Products and Services segment provides a broad range of laboratory equipment. The company has a taxable presence and conducts operations in over 50 countries outside the U.S.

• SIEMENS HEALTHINEERS AG - Siemens Healthineers AG is an affiliate of the German multinational corporation, Siemens AG. The firm is engaged in the creation and marketing of diagnostic imaging & laboratory diagnostics. It offers a comprehensive array of medical technology & software solutions, along with clinical consulting services to healthcare providers, pharmaceutical firms, and research institutions in over 180 countries. In 2001, the firm was christened Siemens Medical Solutions, which was later renamed Siemens Healthcare in 2008. Following a restructuring in 2017, the company adopted Siemens Healthineers as its current name.

• DANAHER - Danaher is a global entity that specializes in the design, production, and marketing of industrial, medical, and commercial goods & services. The company's offerings are primarily distributed through three divisions: Diagnostics, Life Sciences, and Environmental & Applied Solutions. The life sciences division provides technologies for purification, filtration, & separation applicable to various sectors, including medical research, biopharmaceuticals, and food & beverages. Additionally, it supplies reagents, analytical instruments, consumables, and services for laboratories, hospitals, & other healthcare facilities. Previously known as Diversified Mortgage Investors, Inc., the company adopted the name Danaher in 1984. Entities such as Beckman Coulter, Inc. and Molecular Devices operate as subsidiaries of company.

• AGILENT TECHNOLOGIES, INC. - Agilent Technologies, Inc. is dedicated to the development, manufacturing, and research that delivers application-centric solutions to diagnostics, life sciences, and applied chemical sectors worldwide. It functions through three divisions: Diagnostics & Genomics business, Agilent CrossLab business, and Life Sciences & Applied Markets business. Agilent Technologies, Inc. promotes and sells its offerings through electronic commerce, direct sales, manufacturers, resellers, distributors, and representatives. The firm caters to routine and clinical diagnostics markets and analytical labs with a variety of technology platforms such as bioreagents, automation, FISH probes, liquid chromatography, informatics, immunohistochemistry, microarrays, mass spectrometry, and vacuum technologies. In August 2018, Agilent Technologies publicized the successful acquisition of ProZyme, Inc., a biopharmaceutical entity involved in the marketing and distribution of glycobiology products, standards, kits, and reagents.

• BIOTEK INSTRUMENTS, INC. - BioTek Instruments, Inc. is dedicated to the design, production, and distribution of instrumentation for the life sciences. The company's product portfolio includes cell imaging systems, washers, microplate readers, automated incubators, dispensers, and stackers. Additionally, it provides peripheral products to boost workflow efficiency. BioTek caters to applications such as cell culture QC, cell viability/toxicity, cell health and viability, cell metabolism, cell migration/invasion, whole organism imaging, developmental biology, histology, immunology, and microbiology, among others. The firm has operations in Canada, China, France, Germany, India, Japan, the Middle East, South Korea, Switzerland, Taiwan, and the UK. In August 2019, Agilent Technologies publicized the successful acquisition of BioTek Instruments, a firm involved in the design, distribution of life sciences instrumentation, and manufacturing,

• EPPENDORF AG - Eppendorf AG is a life sciences firm that focuses on the creation and sale of consumables, instruments, and services for handling samples, liquids, & cells in laboratories worldwide. The firm's product lineup includes automated pipetting systems, centrifuges, pipettes, dispensers, mixers, DNA amplification equipment, and spectrometers. Additionally, it offers consumables such as test tubes, pipette tips, single-use bioreactor vessels, and microtiter plates. Eppendorf caters to applications such as cell biology, molecular biology, next-generation sequencing, microbiology bioprocessing R&D, physiocare products, and physiocare lab workflows, among others. The firm's local distributors include A. Daigger & Company, BVA Scientific, Cardinal Health, Cole Parmer Instrument Co., and Fisher Scientific, Inc., among others. Furthermore, the firm operates more than 26 subsidiaries globally.

• HUDSON ROBOTICS  - Hudson Robotics is a company that specializes in the marketing and distribution of laboratory automation products. The firm's product lineup includes microplate automation, laboratory robotics, and bespoke software-driven automation for laboratories in the life sciences research field. Hudson also offers tools that have broad applications in areas such as clinical research, genomics, proteomics pharmaceutical development, and drug discovery. The firm carries out its marketing, service, and sales operations in California. Hudson has a distribution network that spans Europe, Australia, South America, and Asia. As a privately owned entity, its financial details have not been disclosed.

• AURORA BIOMED, INC. - Aurora Biomed, Inc. is dedicated to the production of analytical instruments that leverage patented capacitive coupling and plasma emission technology. The technologies devised by the firm are predominantly integrated into various pharmaceutical pipelines for drug discovery and academic laboratories. The firm's offerings are categorized under three key segments: liquid handling equipment, ion channel technologies, and elemental analysis solutions. Aurora caters to a variety of applications including forensics, veterinary medicine, food safety, healthcare, pharmaceutical, diagnostics, environmental, and academics. The firm has a network of local distributors in regions such as Africa, Oceania, Asia, the Middle East, Europe, and North America.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Lab Automation Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Lab Automation Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.